Although there are treatments available in the form of antivirals, we still currently lack a vaccine for HIV.

Although there are treatments available in the form of antivirals, we still currently lack a vaccine for HIV.

Although there are treatments available in the form of antivirals, we still currently lack a vaccine for HIV.

Someone in the world is newly infected with tuberculosis (TB) every second. In 2008 there were an estimated 9.4 million new cases of tuberculosis and 1.8 million deaths.The vast majority of TB deaths are in the developing world, and more than half of all deaths occur in Asia.

Someone in the world is newly infected with tuberculosis (TB) every second. In 2008 there were an estimated 9.4 million new cases of tuberculosis and 1.8 million deaths.The vast majority of TB deaths are in the developing world, and more than half of all deaths occur in Asia.

Life-saving vaccines and medications aren’t distributed equitably around the world; for each child who dies from pneumonia in an industrialized country, more than 2,000 children die from the infection in developing countries.

Life-saving vaccines and medications aren’t distributed equitably around the world; for each child who dies from pneumonia in an industrialized country, more than 2,000 children die from the infection in developing countries.

Life-saving vaccines and medications aren’t distributed equitably around the world; for each child who dies from pneumonia in an industrialized country, more than 2,000 children die from the infection in developing countries.

The clearing and settlement of tropical rainforests has exposed woodcutters, farmers, and ecotourists to new vector-borne diseases.

All of the above are urgently needed in developing nations. A major barrier to achieving these improvements is the underlying weakness of health systems in resource-poor countries, including a shortage of health workers and a lack of disease surveillance programs.

All of the above are urgently needed in developing nations. A major barrier to achieving these improvements is the underlying weakness of health systems in resource-poor countries, including a shortage of health workers and a lack of disease surveillance programs.

All of the above are urgently needed in developing nations. A major barrier to achieving these improvements is the underlying weakness of health systems in resource-poor countries, including a shortage of health workers and a lack of disease surveillance programs.

Since the beginning of the 20th century the number of people in the world has more than quadrupled—from 1.6 billion to nearly 7 billion—and world population is expected to rise to well over 9 billion by 2050.

Since the beginning of the 20th century the number of people in the world has more than quadrupled—from 1.6 billion to nearly 7 billion—and world population is expected to rise to well over 9 billion by 2050.

In 2008, more than 33 million people worldwide were infected with HIV (human immunodeficiency virus). In that same year, an estimated 2 million people died from AIDS (acquired immunodeficiency syndrome), the final stage of HIV infection.

In 2008, more than 33 million people worldwide were infected with HIV (human immunodeficiency virus). In that same year, an estimated 2 million people died from AIDS (acquired immunodeficiency syndrome), the final stage of HIV infection.

About ten trillion microbes live in the human gastrointestinal tract. They are essential for proper digestion and absorption of nutrients.

About ten trillion microbes live in the human gastrointestinal tract. They are essential for proper digestion and absorption of nutrients.

About ten trillion microbes live in the human gastrointestinal tract. They are essential for proper digestion and absorption of nutrients.

Almost 70% of all the antibiotics produced in the United States is added to animal feeds—not to fend off disease but to boost growth. These non-therapeutic uses of antibiotics are a perfect way to cultivate microbes that are resistant to antibiotics.

Almost 70% of all the antibiotics produced in the United States is added to animal feeds—not to fend off disease but to boost growth. These non-therapeutic uses of antibiotics are a perfect way to cultivate microbes that are resistant to antibiotics.